Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-05-30
2006-05-30
Ketter, James (Department: 1636)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100
Reexamination Certificate
active
07053194
ABSTRACT:
Compositions and methods are provided for identifying novel therapeutic agents for the treatment of cancer and other cellular proliferative disorders.
REFERENCES:
Bao, R. et al. “Activation of Cancer-Specific Gene Expression by the Survivin Promoter”; Journal of the National Cancer Institute, 94(7): 522-528 (2002).
Hoffman, W.H. et al. “Transcriptional Repression of the Anti-apoptoticsurvivinGene by Wild Type p53”, 277(5): 3247-3257 (2002).
Yang, L. et al. “Tumor-specific gene expression using the survivin promoter is further increased by hypoxia”; Gene Therapy, 11: 1215-1233 (2004).
Dann Dorfman Herrell & Skillman
Fox Chase Cancer Center
Garvey Tara L.
Ketter James
Rigaut Kathleen D.
LandOfFree
Compositions and methods for p53-mediated repression of gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for p53-mediated repression of gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for p53-mediated repression of gene... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3538707